OncoCyte Corporation – Trademark Portfolio
Entity Type: 03
OncoCyte Corporation holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 21 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. Currently, 4 trademarks are registered and 10 are pending. Notable registered marks include ONCOCYTE, DETERMARX, and DETERMA RX IO TX. The owner is based in Irvine, CA.
15 Cushing
Irvine, CA 92618
Showing of trademarks Trademarks
Trademark Classifications
OncoCyte Corporation's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does OncoCyte Corporation have?
OncoCyte Corporation has 27 U.S. trademarks filed with the USPTO. Of these, 4 registered, 10 pending, 13 abandoned.
What trademark classes does OncoCyte Corporation file in?
OncoCyte Corporation files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are OncoCyte Corporation's most well-known trademarks?
OncoCyte Corporation's registered trademark portfolio includes well-known marks such as ONCOCYTE, DETERMARX, and DETERMA RX IO TX. These are among 4 currently registered trademarks in the portfolio.
What is OncoCyte Corporation's trademark registration success rate?
OncoCyte Corporation has a 24% trademark registration rate, with 4 out of 17 resolved applications resulting in successful registration. Currently, 10 applications are pending review.